Evommune to Present at Evercore Healthcare Conference
Evommune, Inc. will present at the 9th Annual Evercore Healthcare Conference on December 2, 2026 at 10:25 am EST in Coral Gables, FL with a webcast available. Separately, the company announced that positive Phase 2a topline data for EVO301 in moderate-to-severe atopic dermatitis will be presented as a late-breaker oral session at the European Academy of Dermatology & Venereology Congress on October 1, 2026.
Read source-backed brief